Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Cover

Oncology Research and Treatment

Editor(s): Hallek M. (Cologne) 

Editorial Board

Affiliations

Loading, please wait Editor's Choice loading, please wait...
Vol. Issue pp. Issue Release Date
41 Suppl. 1 - February 2018
Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben
Vol. Issue pp. Issue Release Date
40 No. 12 733-820 December 2017
40 No. 11 645-732 October 2017
40 No. 10 569-644 October 2017
40 No. 9 477-566 September 2017
40 No. 7-8 430-476 August 2017
40 No. 6 313-396 June 2017
40 No. 5 281-312 May 2017
40 No. 4 165-235 April 2017
40 No. 3 73-163 March 2017
40 No. 1-2 1-71 February 2017
40 Suppl. 3 1-308 September 2017
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Medizinische Onkologie
40 Suppl. 2 1-12 April 2017
Therapie des metastasierten kastrationsresistenten Prostatakarzinoms mit Abirateronacetat
40 Suppl. 1 1-19 March 2017
Supportive Therapie und Rehabilitation bei Krebs – State of the Art 2017
Vol. Issue pp. Issue Release Date
39 No. 12 749-856 December 2016
39 No. 11 677-748 November 2016
39 No. 10 581-676 October 2016
39 No. 9 493-580 September 2016
39 No. 7-8 413-491 August 2016
39 No. 6 317-411 June 2016
39 No. 5 253-316 May 2016
39 No. 4 173-252 April 2016
39 No. 3 93-172 March 2016
39 No. 1-2 1-92 February 2016
39 Suppl. 4 1-12 November 2016
Immunonkologie: Von der Mono- zur Kombinationstherapie
39 Suppl. 3 1-348 October 2016
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Medizinische Onkologie
39 Suppl. 2 1-24 September 2016
Molekulargenetische Diagnostik - Was wissen die Maschinen? Was wollen wir wissen?
39 Suppl. 1 1-191 February 2016
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ